Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool

por McChalicher, Christopher W J, Lombardo, Mary-Jane, Khanna, Sahil, McKenzie, Gregory J, Halvorsen, Elizabeth M, Almomani, Sanabel, Schuster, Brian, Hasson, Brooke R, McGovern, Barbara H, Ege, David S, Auniņš, John G
Publicado 2023

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI)

por Khanna, Sahil, Sims, Matthew, Louie, Thomas J., Fischer, Monika, LaPlante, Kerry, Allegretti, Jessica, Hasson, Brooke R., Fonte, Allyson T., McChalicher, Christopher, Ege, David S., Bryant, Jessica A., Straub, Timothy J., Ford, Christopher B., Henn, Matthew R., Wang, Elaine E. L., von Moltke, Lisa, Wilcox, Mark H.
Publicado 2022

Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota–Based Therapeutic

por Berenson, Charles S, Lashner, Bret, Korman, Louis Y, Hohmann, Elizabeth, Deshpande, Abhishek, Louie, Thomas J, Sims, Matthew, Pardi, Darrell, Kraft, Colleen S, Wang, Elaine E L, Cohen, Stuart H, Feuerstadt, Paul, Oneto, Caterina, Misra, Bharat, Pullman, John, De, Ananya, Memisoglu, Asli, Lombardi, David A, Hasson, Brooke R, McGovern, Barbara H, von Moltke, Lisa, Lee, Christine H
Publicado 2023

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial

por Sims, Matthew D., Khanna, Sahil, Feuerstadt, Paul, Louie, Thomas J., Kelly, Colleen R., Huang, Edward S., Hohmann, Elizabeth L., Wang, Elaine E. L., Oneto, Caterina, Cohen, Stuart H., Berenson, Charles S., Korman, Louis, Lee, Christine, Lashner, Bret, Kraft, Colleen S., Ramesh, Mayur, Silverman, Michael, Pardi, Darrell S., De, Ananya, Memisoglu, Asli, Lombardi, David A., Hasson, Brooke R., McGovern, Barbara H., von Moltke, Lisa
Publicado 2023